Stereotactic body radiotherapy for central lung tumors, yes we can!

BACKGROUND: SBRT is standard therapy for early stage lung cancer. Toxicity in central tumors has been a concern. RTOG 0813 showed that central SBRT is safe and effective. We report our experience with central SBRT. METHODS: We reviewed the records of patients treated with SBRT for central lung tumor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Radiat Oncol
Main Authors: Korzets ceder, Yasmin, Fenig, Eyal, Popvtzer, Aron, Peled, Nir, Kramer, Mordechai R., Saute, Milton, Bragilovsky, Dima, Schochat, Tzippy, Allen, Aaron M.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918762/
https://ncbi.nlm.nih.gov/pubmed/29695273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-1017-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki